Back

Cell fusion upregulates PD-L1 expression and promotes tumor formation

Masai, H.; Tajima, Y.; Shibazaki, F.

2022-06-17 cancer biology
10.1101/2022.06.14.496068 bioRxiv
Show abstract

MSCs (mesenchymal stem cells), responsible for tissue repair, rarely undergo cell fusion with somatic cells. Here, we show that approximately 5% of bladder cancer cells (UMUC-3) fuses with bone marrow-derived MSC (BM-MSC) in co-culture and exhibits increased tumorigenicity. Eleven fusion cell clones are established, and 116 genes are identified whose expression is specifically altered in the fusion cells. Many of them are interferon-stimulated genes (ISG), but are activated in a manner independent of interferon. Among them, we show that PD-L1 is induced in fusion cells, and its knockout decreases tumorigenesis in a xenograft model. PD-L1 is induced in a manner independent of STAT1 known to regulate PD-L1 expression, but is regulated by histone modification, and is likely to inhibit phagocytosis by PD1-expressing macrophages, thus protecting cancer cells from immunological attacks. The fusion cells overexpress multiple cytokines including CCL2 that causes tumor progression by converting infiltrating macrophages to tumor-associated-macrophage (TAM). The results present mechanisms of how cell fusion promotes tumorigenesis, revealing a novel link between cell fusion and PD-L1, and underscores the efficacy of cancer immunotherapy.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
eLife
● 5828 papers in training set
Top 6%
13.2%
Similar papers in this journal
2
Cancer Letters
○ 35 papers in training set
Top 0.1%
7.4%
Similar papers in this journal
3
iScience
○ 1154 papers in training set
Top 1%
6.4%
Similar papers in this journal
4
Experimental Cell Research
○ 28 papers in training set
Top 0.1%
4.9%
Similar papers in this journal
5
Cell Death & Disease
147 papers in training set
Top 0.8%
3.3%
6
Scientific Reports
○ 3612 papers in training set
Top 32%
3.2%
7
Cells
○ 249 papers in training set
Top 1%
2.8%
8
Molecular Therapy - Nucleic Acids
○ 25 papers in training set
Top 0.2%
2.7%
9
Oncogenesis
○ 12 papers in training set
Top 0.1%
2.4%
10
Cancers
○ 213 papers in training set
Top 2%
2.4%
11
Communications Biology
○ 993 papers in training set
Top 12%
1.9%
50% of probability mass above
12
Aging
○ 75 papers in training set
Top 0.8%
1.8%
13
Journal of Experimental & Clinical Cancer Research
○ 25 papers in training set
Top 0.3%
1.7%
14
EMBO Reports
○ 263 papers in training set
Top 3%
1.7%
15
Stem Cell Research & Therapy
○ 30 papers in training set
Top 0.4%
1.5%
16
Theranostics
● 37 papers in training set
Top 0.5%
1.5%
17
Molecular Oncology
○ 55 papers in training set
Top 0.7%
1.5%
18
Biology Open
● 156 papers in training set
Top 2%
1.5%
19
Frontiers in Cell and Developmental Biology
○ 233 papers in training set
Top 3%
1.4%
20
Cell Death Discovery
○ 58 papers in training set
Top 0.8%
1.1%
21
Cell Reports
○ 1498 papers in training set
Top 22%
1.1%
22
Neoplasia
○ 23 papers in training set
Top 0.5%
1.1%
23
European Journal of Cell Biology
○ 15 papers in training set
Top 0.1%
1.1%
24
Molecular and Cellular Biology
○ 47 papers in training set
Top 0.5%
1.1%
25
PLOS ONE
● 5266 papers in training set
Top 52%
1.1%
26
Biochemical and Biophysical Research Communications
○ 84 papers in training set
Top 2%
1.1%
27
Life Science Alliance
● 285 papers in training set
Top 6%
1.0%
28
Molecular Therapy Nucleic Acids
○ 39 papers in training set
Top 0.8%
0.9%
29
Translational Oncology
○ 21 papers in training set
Top 0.8%
0.9%
30
Oncogene
○ 85 papers in training set
Top 2%
0.9%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.